Our portfolio

longform.ai

Transforming audio conversations into actionable insights, longform.ai provides data-driven analysis for investment and trading companies. Their technology converts audio data into structured insights, enhancing decision-making processes. Longform.ai targets markets in Europe and the United States, catering to investment funds and hedge funds. The company is dedicated to revolutionizing data analysis through innovative AI solutions.

Industry: AI, Business, Data

Want to get in contact about longform.ai?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Amplifying treatment of chronic autoimmune diseases.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Developing bispecific antibodies as enhanced cancer immunotherapy.
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Amplifying treatment of chronic autoimmune diseases.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Developing bispecific antibodies as enhanced cancer immunotherapy.
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.